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Dendritic cells (DCs) are outstanding antigen presenting cells (APCs) due to their
robust ability to internalize extracellular antigens using endocytic processes such as
receptor-mediated endocytosis, phagocytosis, and macropinocytosis. Macropinocytosis
mediates the non-specific uptake of soluble antigens and occurs in DCs constitutively.
Macropinocytosis plays a key role in DC-mediated antigen presentation to T cells against
pathogens and the efficiency of macropinocytosis in antigen capture is regulated during
the process of DC maturation. Here, we review the methods to study macropinocytosis,
describe our current knowledge of the regulatory mechanisms of antigen uptake via
macropinocytosis and the intracellular trafficking route followed by macropinocytosed
antigens, and discuss the significance of macropinocytosis for DC function.
Keywords: dendritic cell, macropinocytosis, endocytosis, MHC class II, antigen presentation
INTRODUCTION
Dendritic cells (DCs) are the most accomplished of profes-
sional antigen presenting cells (APCs) and are responsible
for initiating T cell responses against pathogens (Villadangos
and Schnorrer, 2007). DCs are present throughout the body
and function by sampling their microenvironment to “sense”
pathogens. DCs express peptide fragments of degraded for-
eign antigens on their surface bound to MHC glycoproteins,
molecules that function as “display platforms” presenting
peptide-fragments for recognition by antigen-specific T cells
(Blum et al., 2013). Peptide-MHC class I complexes (pMHC-I)
are recognized by cytotoxic CD8+ T cells whereas peptide-
MHC class II complexes (pMHC-II) are recognized by helper
CD4+ T cells. Besides stimulating distinct classes of T cells,
it is generally true that MHC-I and MHC-II differ in the
sites of intracellular antigenic peptide generation. MHC-I-
destined peptides are generated by cytosolic proteolysis of
endogenous proteins and foreign (often viral) antigens, and
these peptides are translocated into the endoplasmic reticulum
for binding to nascent MHC-I. In specialized DC subsets,
however, these peptides can be translocated directly into
phagosomes for binding to MHC-I in a process termed cross-
presentation (Joffre et al., 2012). Cross-presentation can also
result from direct endo/lysosomal proteolysis of internalized
antigens (Shen et al., 2004; Kreer et al., 2011), however this
review will not address the endocytic mechanisms responsi-
ble for cross-presentation as this has been reviewed recently
(Schuette and Burgdorf, 2014). By marked contrast with
MHC-I, MHC-II-destined peptides are often generated by
endo/lysosomal proteolysis of internalized pathogens. DCs
generally recognize and capture foreign invaders in non-
lymphoid organs. Upon pathogen capture, DCs concurrently
mature and migrate to secondary lymphoid organs (such
as lymph nodes) where their surface pMHC-I and pMHC-II
present antigenic peptides to T cells to initiate antigen-specific
adaptive immune responses.
One feature that makes DCs particularly effective stimulators
of CD4+ T cell responses is their considerable capacity to acquire
exogenous antigens/pathogens by a variety of different endocytic
processes (Figure 1). Receptor-mediated endocytosis requires
antigen (usually small soluble molecules) binding to a variety of
receptors on DCs (most notably lectins, Fc receptors, and com-
plement receptors) that are internalized in clathrin-coated and
non-clathrin-coated vesicles. Phagocytosis is a form of endocyto-
sis that mediates the internalization of a wide-variety of relatively-
large insoluble particulate antigens including necrotic/apoptotic
cells and opsonized pathogenic organisms/viruses (Stuart and
Ezekowitz, 2005). Like receptor-mediated endocytosis, phago-
cytosis is usually initiated by antigen binding to DC surface
“receptors,” however, DCs can also internalize large particles
(such as antigen-coated latex beads) by non-specific phagocytosis.
Lastly, macropinocytosis (Lim and Gleeson, 2011), or “cell drink-
ing,” is the non-specific uptake of soluble molecules, nutrients
and antigens. By contrast, phagocytosis and receptor-mediated
endocytosis mediate specific uptake of extracellular materials
via a number of distinct surface receptors (Burgdorf and Kurts,
2008). Macropinocytosis is an actin-dependent process initiated
from plasma membrane ruffles that give rise to large endo-
cytic vesicles called macropinosomes, which are distinct from
other forms of endocytic vesicles. Unlike small (0.1μm) clathrin-
coated vesicles, macropinosomes have no apparent coat struc-
ture and are heterogeneous in size ranging from 0.2 to 5μm
in diameter (Hewlett et al., 1994; Swanson and Watts, 1995).
Macropinocytosis occurs constitutively in DCs and DCs gener-
ated in vitro from mouse bone marrow (BMDC) can internalize
approximately 2 fL/cell/min (Norbury et al., 1997), thereby pro-
viding these cells with a robust mechanism of non-specific foreign
antigen uptake.
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FIGURE 1 | Pathways of Exogenous Antigen Uptake in DCs. DCs
internalize extracellular antigens using three main endocytic pathways.
Phagocytosis is an endocytic process in which opsonized particles bind
to specific receptors on the DC surface and enter cells in
membrane-derived phagosomes. Phagocytosed antigens (Blue) can fuse
with MHC-II+ lysosomes to generate phagolysosomes (not shown) or
can be directly targeted into late endosomal/lysosomal antigen
processing compartments to generate pMHC-II complexes.
Macropinocytosis mediates non-specific uptake of soluble antigens into
the cell via macropinosomes. Antigens in macropinosomes (Red) are
transferred into early endosomes that eventually fuse with multivesicular
late endosomal/lysosomal antigen processing compartments.
Macropinocytosed antigens are degraded and loaded on MHC-II in
these compartments. Receptor-mediated endocytosis is a process in
which small soluble antigens bind to specific receptors on the DC
surface that internalize in clathrin-coated vesicles or in clathrin-uncoated
vesicles (not shown). Following uncoating of clathrin, antigens in
clathrin-coated vesicles (Purple) are delivered to early endosomes and
eventually to antigen processing compartments for proteolytic
degradation and pMHC-II formation. After formation in antigen
processing compartments, pMHC-II complexes traffic to plasma
membrane to initiate antigen-specific adaptive immune responses.
METHODS TO STUDY MACROPINOCYTOSIS IN DCs
Since foreign-antigen uptake and proteolysis are such impor-
tant functions of DCs, a variety of tools have been devel-
oped to study the mechanisms of antigen uptake in these cells.
Quantitating the uptake of fluorescently-labeled molecules [often
BSA, dextran, or ovalbumin (OVA)] or the fluorescent dye Lucifer
Yellow (LY) is a standard method for measuring antigen uptake
via macropinocytosis. However, in many of the studies per-
formed to date it has been difficult to unambiguously distinguish
between macropinocytosis and receptor-mediated endocytosis
as the mechanims of “antigen” uptake in DCs. Whereas both
fluorescently-labeled dextran and OVA have been used to mea-
sure uptake via “macropincytosis,” partial suppression of uptake
by pretreatment with the mannose receptor-agonist mannan
demonstrates that dextran and OVA are also internalized by
mannose receptor-mediated endocytosis (Sallusto et al., 1995;
Burgdorf et al., 2006; Platt et al., 2010). Thus, the choice of solute
marker examined, and exact experimental protocol followed, are
the key to knowing precisely which endocytic pathway is actually
being assayed.
In addition, a number of inhibitors have been used
to “specifically” study macropinocytosis. Inhibitiors of the
amiloride family (amiloride, EIPA, HOE-694, and DMA) inhibit
Na+/H+ exchanger activity that promotes actin polymeriza-
tion during macropinocytosis. Sanglifehrin A and rapamycin
are immunophilin-binding agents that exert immunosuppressive
effects on DC functions including macropinocytosis (Sallusto
et al., 1995; Hackstein et al., 2002, 2007). However, other stud-
ies revealed that these compounds also inhibit receptor-mediated
endocytosis (Hackstein et al., 2002, 2007; Sarkar et al., 2005;
Koivusalo et al., 2010). The same issue occurs when using PI3-
kinase inhibitors (wortmannin and LY294002) and cytochalasins
as inhibitors of macropinocytosis. These inhibitors function by
blocking actin polymerization and therefore they not only reduce
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macropinocytosis but also inhibit phagocytosis in DCs (Araki
et al., 1996, 2003). Low doses (<3μM) of the PKCδ inhibitor
Rottlerin significantly reduce uptake of Lucifer Yellow, but not
transferrin, in DCs, suggesting that this compound preferentially
blocks macropinocytosis in this cell type (Sarkar et al., 2005).
However, Rottlerin has been shown to inhibit dectin-1-mediated
phagocytosis of zymosan in monocytes when used at a concen-
tration of 5μM (Elsori et al., 2011), calling into question the
specificity of this compound as an inhibitor of macropinocyto-
sis. All the above data suggest that it is very difficult to specifically
study the importance of macropinocytosis per se in DC antigen
presenting function. More selective and efficient inhibitors need
to be identified for investigation of the functional significance of
macropinocytosis in the future.
REGULATION OF MACROPINOCYTOSIS IN DCs
Most DCs exist in vivo in a quiescent “immature” state that can
be converted to an activated “mature” state by exposure to a wide
variety of stimulatory ligands.Whereas immature DCs have a very
robust process of constitutive macropinocytosis, DCs lose this
ability upon activation/maturation. The original observation of
this phenomenon was made in DCs generated from human blood
monocytes in vitro (Sallusto et al., 1995). These in vitro-cultured
immature DCs can take up about 1–1.5 pL of extracellular fluid
per hour, representing nearly the entire volume of cell itself.
Addition of stimuli that induce the maturation of DCs (including
TNF-α, IL-1β, CD40L, and a variety of TLR-ligands) profoundly
suppresses macropinocytosis. Efficient macropinocytosis cannot
be recovered when these stimuli are removed, demonstrating that
an irreversible termination of macropinocytosis occurs upon DC
maturation. Suppression of macropinocytosis upon DC matura-
tion has been shown in mouse BMDC (Garrett et al., 2000) and
in in vitro activated spleen DCs (West et al., 2000).
As in other non-immune cells, macropinocytosis in DCs
is controlled by the Rho GTPase Cdc42 and Rac-dependent
remodeling of the actin cytoskeleton. Immature DCs pos-
sess large amounts of GTP-bound Cdc42 whose expression is
greatly diminished upon DC activation (Garrett et al., 2000).
Injection of dominant-negative forms of Cdc42 or Rac blocked
macropinocytosis in immature DC, whereas overexpression
of constitutively-active forms of these same GTPases restored
macropinocytosis in mature DCs (Garrett et al., 2000), revealing
a direct role of these proteins in the modulation of macropinocy-
tosis in DCs. Interestingly, kinetic studies of macropinocytosis in
DCs showed that TLR stimulation of DCs transiently enhanced
antigen macropinocytosis in the first few hours, a process that
was then followed by dramatic suppression of macropinocytosis
hours later (West et al., 2004). LPS and other TLR ligands tran-
siently activated MAP kinase activity and stimulated actin poly-
merization and disassembly of actin-rich podosomes, thereby
resulting in increased accumulation of fluorescent antigen-filled
macropinosomes in DCs. However, this acute actin remodeling
was not dependent on Rac or Cdc42 (West et al., 2004). It is
thought that this transient burst in macropinocytosis in imma-
ture DCs serves to maximize antigen capture and presentation
of relevant antigens associated with the inflammatory source
of DC activation. It is interesting to note that TLR signaling
promotes the formation of phagolysosomes following phago-
cytosis (Blander and Medzhitov, 2006), and it is an intriguing
possibility that TLR signaling enhances not only the kinetics of
antigen uptake following macropinocytosis but also enhances
the “maturation” of macropinosomes into proteolytic antigen
processing compartments.
The finding that macropinocytosis is dramatically suppressed
upon DCs maturation fits well with the idea that DCs specifi-
cally acquire pathogens at the time of their activation in vivo and
that after activation additional pathogen uptake is unnecessary
(or even undesirable). It has therefore been widely accepted that
immature DCs are the primary antigen samplers of peripheral
tissues and that maturation convert DCs from efficient anti-
gen sampling cells to efficient antigen presenting cells. There are,
however, compelling data challenging this hypothesis. Drutman
et al. showed that injection of mice with the inflammatory
mediators LPS or CpG resulted in efficient in vivo DC matu-
ration. Surprisingly, subsequent immunization of these “in vivo
activated” mice with the model antigen OVA resulted in efficient
stimulation of OVA-specific CD8+ and CD4+ T cells both ex vivo
and in vivo, suggesting that in vivo activated DCs are still able
to take up antigens and present them to T cells (Drutman and
Trombetta, 2010). In contradiction to results obtained in vitro,
direct measurements of antigen uptake confirmed that antigen
delivered in vivo was internalized by macropinocytosis equally
well by immature DCs and in vivo matured DCs. Importantly,
in this study the authors confirmed the many previous findings
that in vitro activation almost completely blocks macropinocy-
tosis in DCs, highlighting the differences in the regulation of
macropinocytosis in DCs activated in vitro versus DCs activated
in vivo. Platt et al. also found that mature spleen DCs isolated
from mice injected with LPS possessed robust macropinocyto-
sis activity and were able to stimulate OVA-specific CD4+ T
cells when assayed ex vivo (Platt et al., 2010), supporting the
idea that in vivo activation of DCs does not profoundly reduce
macropinocytosis and that in vivo activated DCs can generate
pMHC-II capable of stimulating naïve CD4+ T cells.
The robust ability of in vivomatured DCs to internalize soluble
antigen and subsequently generate pMHC-II complexes capa-
ble of stimulating antigen-specific T cell has not been seen in
other studies. While Young et al. also found that spleen DCs
from control mice and CpG-injected (i.e., in vivo matured)-
mice internalized comparable amounts of soluble OVA antigen
ex vivo (Young et al., 2007), in their study in vivo-activated spleen
DCs were unable to stimulate OVA-specific CD4+ T cells (Young
et al., 2007). The authors attributed this finding to impaired
formation of MHC-II-peptide complexes in the mature DCs
(due to the down-regulation of MHC-II biosynthesis) but not
to impaired antigen uptake. Despite conflicting results regard-
ing the extent of T cell activation by in vivo-activated DCs, each
of these studies demonstrates that unlike in vitro matured DCs,
in vivo matured spleen DCs can still internalize foreign solu-
ble antigens, most likely via macropinocytosis. It is important
to remember, however, that simply internalizing antigens is not
sufficient for APC function; DCs must generate antigen-specific
pMHC-II complexes from the internalized antigens in order to
activate antigen-specific T cells ex vivo or in vivo. Factors that
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affect pMHC-II formation in immature vs. mature DCs [such as
diminished biosynthesis of MHC-II (Cella et al., 1997), altered
intracellular localization of MHC-II (Turley et al., 2000), or dif-
ferences in endo/lysosomal proteinase activity (Trombetta et al.,
2003)] will contribute to the efficiency of pMHC-II formation in
mature DCs regardless of whether macropinocytosis is intact or
not, as highlighted by the findings of the abovementioned studies.
There is also evidence showing that the extent of macropinocy-
tosis varies among different types of DCs. Conventional DCs
(cDCs) in the spleen capture significantly more soluble fluores-
cent OVA than plasmacytoid DCs (pDCs) do in vitro, however
this difference was not seen in vivo (Young et al., 2008). While
CD8+ and CD8− cDCs internalize similar amounts of soluble
OVA and BSA in vitro, these DC subsets target the internalized
antigens into distinct intracellular compartments and present
them to different classes of T cells (Schnorrer et al., 2006). In
lung parenchyma, CD11bhiCD103− DCs preferentially internal-
ize soluble OVA protein for presentation on MHC-II to CD4+
T cells, whereas CD11blowCD103+ DCs preferentially phagocy-
tose OVA-coated latex beads for presentation onMHC-I to induce
CD8+ T cell responses (Jakubzick et al., 2008). Finally, in the
skin Langerin− dermal DCs internalize more soluble OVA than
do Langerin+ epidermal DCs (Sparber et al., 2010). However, it
is unclear whether OVA uptake in these distinct DC populations
is mediated solely via macropinocytosis, as it has been shown that
Langerin− dermal DCs express higher amounts of OVA-binding
mannose receptors than do Langerin+ epidermal DCs (Turville
et al., 2002).
INTRACELLULAR TRAFFICKING OF PINOCYTOSED ANTIGENS
Since one of the major functions of DCs is to process extracellu-
lar antigens into small peptides capable of generating pMHC-II
complexes, the delivery of foreign antigens to the appropriate
antigen-processing compartment is a crucial step in the induc-
tion of T cell responses. Sallusto et al. showed that immature DCs
internalized and delivered the fluid phase marker FITC-dextran
to a large compartment that contains MHC-II, cathepsin D, and
LAMP-1, suggesting that macropinocytosed antigen was trans-
ported to late endosomes/lysosomes for degradation and pMHC-
II formation (Sallusto et al., 1995). Subsequent studies con-
firmed this intracellular routing pathway of macropinocytosis.
Macropinocytosed LY accumulates in late endosomes/lysosomes
identified by Lysotracker but not in organelles expressing the
early endosomal markers Rab5 and EEA-1 (Burgdorf et al.,
2007). All these studies demonstrate that antigen endocytosed
within macropinosomes is targeted to late endosomal/lysosomal
MHC-II antigen processing compartments that are specialized for
induction of CD4+ T cell responses.
Unlike macropinocytosis, receptor-mediated endocytosis can
deliver antigens to distinct classes of endosomes in DCs. Mannose
receptor-endocytosed OVA is preferentially delivered to an early
endosomal compartment, and antigen targeting to this com-
partment generally leads to poor OVA processing and MHC-II
presentation to CD4+ T cells (Burgdorf et al., 2007). By con-
trast, Fcγ receptor or DEC205-endocytosed OVA is transported
rapidly to late endosomes/lysosomes for very efficient MHC-II
antigen processing and presentation to OVA-specific T cells (Platt
et al., 2010). These studies demonstrate that lysosomal targeting
(and presumably proteolysis) of internalized antigens enhances
MHC-II-restricted antigen presentation to CD4+ T cells.
SIGNIFICANCE OF MACROPINOCYTOSIS FOR DC FUNCTION
All APC subtypes are able to take up extracellular molecules, anti-
gens, and nutrients. Macrophages primarily use surface receptor-
dependent phagocytosis to engulf pathogens and apoptotic cells
(Aderem and Underhill, 1999), while B cells primarily use their
antigen-specific B cell receptor (BCR) to target specific anti-
gens to antigen processing compartments (Lanzavecchia, 1990).
By contrast, DCs use macropinocytosis as a major mechanism
to sample their microenvironment. Thus efficient, constitutive
macropinocytosis distinguishes DCs from macrophages and B
cells as APCs capable of sampling tissues without regard to
endocytic “receptor” specificity.
In the absence of infection or inflammation, immature DCs
use macropinocytosis to constitutively capture self-antigen and
present self-pMHC-II complexes to induce regulatory T cells in
lymphoid organs (Steinman et al., 2003; Wilson et al., 2004),
strongly suggesting that macropinocytosis contributes to DC-
induced peripheral tolerance. Recent studies showed that imma-
ture peripheral plasmacytoid DCs (pDCs) can transport OVA
peptide or OVA expressed in a tissue-specific manner to the thy-
mus and induce clonal depletion of OVA-specific thymocytes
(Bonasio et al., 2006; Hadeiba et al., 2012), indicating that con-
stitutive macropinocytosis of antigens by DCs in the periphery
may also contribute to the establishment of central tolerance.
However, given the demonstration that some fraction of OVA
enters cell by receptor-mediated endocytosis (Burgdorf et al.,
2007), it remains an open question as to whether macropinocy-
tosis alone is responsible for central tolerance induction in the
thymus. Further studies are needed to determine whether, and
to what extent, DC macropinocytic uptake of peripheral antigens
contributes to central tolerance.
In the presence of infection or under inflammatory condi-
tions, DCs employ macropinocytosis to internalize the soluble
pathogenic antigens, degrade them into antigenic peptides, and
present these antigenic pMHC-II complexes to CD4+ T cells. A
number of studies have shown that macropinocytosis is impor-
tant for MHC-II antigen presentation by DCs both in vitro and
in vivo. Administration of macropinocytosis inhibitors not only
reduces the amount of antigen taken up by DCs but also lim-
its their capacity to stimulate antigen-specific CD4+ T cells. This
finding has been validated using various model systems, includ-
ing adoptive transfer of alloantigen-pulsed DCs into syngeneic
mice as well as in ex vivo studies using antigen-pulsed APCs to
stimulate a wide-variety of mouse and human antigen-specific
CD4+ T cells (Sarkar et al., 2005; Hackstein et al., 2007; von
Delwig et al., 2006; Drutman and Trombetta, 2010). Together,
these studies demonstrate that interfering with antigen uptake via
macropinocytosis results in impaired MHC-II antigen presenta-
tion by DCs.
Although macropinocytosis plays an important role in
DC-mediated immune protection, pathogens can exploit the
macropinocytosis machinery to gain access to host cells.
Recent studies have shown that many different viruses use the
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macropinocytosis pathway to enter host cells and cause infection.
Viruses possessing this ability include vaccinia virus, adenovirus
3, echovirus 1, coxsackievirus B, Herpes simplex virus 1, and
human immunodeficiency virus (Mercer and Helenius, 2009).
Each of these viruses activates small GTPases or kinases that
stimulate macropinocytosis in host cells, thereby enhancing viral
entry. These viruses colocalize with fluid-phase makers within
infected cells, providing another line of evidence that viruses
enter host cells through macropinocytosis. Although these stud-
ies were not directly performed using DCs as host cells, there
is no reason to believe that these viruses do not also affect
macropinocytiosis in DCs. One consequence of macropinocy-
tosed vaccinia virus into DCs is that DC maturation itself is
suppressed (Engelmayer et al., 1999), thereby reducing the pos-
sibility of an anti-vaccinia virus immune response. HIV-1 enters
DCs by both receptor mediated endocytosis and macropinocyto-
sis, however it is themacropinocytosis pathway that contributes to
DC-mediated HIV-1 trans-infection of CD4+ cells (Wang et al.,
2008), revealing a role of macropinocytosis in propagating HIV
infection. These data therefore provide new insights into the role
of macropinocytosis in DC-mediated immune responses.
CONCLUSION
It is important to note that most of our current knowledge of the
role of macropinocytosis in DC function has been acquired using
in vitro culture systems. The contribution of macropinocytosis for
DC function has not been fully tested in vivo, however this would
require development of effective strategies to specifically disrupt
macropinocytosis in vivo. Discovering specific inhibitors or gen-
erating mice containing mutations of known macropinocytosis
regulators, such as Rac1 and Cdc42, is required to fully under-
stand the contribution of this endocytic pathway to DC function
in a physiological setting.
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